Scrutiny Continues to Grow Around the Cost of Specialty Drugs

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Related Videos
Related Content

IQVIA Reports Pharmacy Industry Trends at NACDS Regional Conference

February 3rd 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Report Outlines Pharmacists’ Essential Role in Vaccinations

February 3rd 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

Technology Can Help Ease Provider Burnout, Access to Health Care

February 1st 2023

Medicaid Patients With NSCLC May Be Undertreated With Life-prolonging Targeted Therapies

February 1st 2023

IQVIA Reports Pharmacy Industry Trends at NACDS Regional Conference

February 3rd 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Report Outlines Pharmacists’ Essential Role in Vaccinations

February 3rd 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

Technology Can Help Ease Provider Burnout, Access to Health Care

February 1st 2023

Medicaid Patients With NSCLC May Be Undertreated With Life-prolonging Targeted Therapies

February 1st 2023

IQVIA Reports Pharmacy Industry Trends at NACDS Regional Conference

February 3rd 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Report Outlines Pharmacists’ Essential Role in Vaccinations

February 3rd 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

Technology Can Help Ease Provider Burnout, Access to Health Care

February 1st 2023

Medicaid Patients With NSCLC May Be Undertreated With Life-prolonging Targeted Therapies

February 1st 2023
About Us
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.